This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Muneshige Shimizu: Innovator in Muscle Atrophy Research
Introduction
Muneshige Shimizu is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the area of muscle health. His innovative work focuses on developing solutions to combat muscular atrophy, a condition that can severely impact quality of life.
Latest Patents
Shimizu holds a patent for a composition aimed at suppressing muscular atrophy. This composition includes active ingredients such as one or more peptides selected from a specific group, including tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK. Additionally, it comprises dipeptides that play a crucial role in muscle preservation.
Career Highlights
Throughout his career, Muneshige Shimizu has been associated with Otsuka Pharmaceutical Company, Limited. His work at this esteemed organization has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in health and wellness.
Collaborations
Shimizu has collaborated with notable colleagues, including Kiyohiko Magata and Koichiro Hamada. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Muneshige Shimizu's contributions to the field of muscle health through his innovative patent demonstrate his commitment to improving human health. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile